DGX Quest Diagnostics Inc

Price (delayed)

$141.28

Market cap

$15.7B

P/E Ratio

18.76

Dividend/share

$2.88

EPS

$7.53

Enterprise value

$20.57B

Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals ...

Highlights
DGX's EPS is up by 9% year-on-year
The net income has grown by 7% YoY
DGX's price to earnings (P/E) is 27% higher than its 5-year quarterly average of 14.8
Quest Diagnostics's quick ratio has decreased by 26% YoY and by 25% QoQ

Key stats

What are the main financial stats of DGX
Market
Shares outstanding
111.09M
Market cap
$15.7B
Enterprise value
$20.57B
Valuations
Price to book (P/B)
2.43
Price to sales (P/S)
1.69
EV/EBIT
16.39
EV/EBITDA
12.08
EV/Sales
2.22
Earnings
Revenue
$9.29B
EBIT
$1.26B
EBITDA
$1.7B
Free cash flow
$947M
Per share
EPS
$7.53
Free cash flow per share
$8.53
Book value per share
$58.1
Revenue per share
$83.67
TBVPS
$44.43
Balance sheet
Total assets
$13.95B
Total liabilities
$7.49B
Debt
$5.35B
Equity
$6.43B
Working capital
-$70M
Liquidity
Debt to equity
0.83
Current ratio
0.97
Quick ratio
0.78
Net debt/EBITDA
2.86
Margins
EBITDA margin
18.3%
Gross margin
32.9%
Net margin
9.1%
Operating margin
13.5%
Efficiency
Return on assets
6.2%
Return on equity
13.3%
Return on invested capital
16.4%
Return on capital employed
10.8%
Return on sales
13.5%
Dividend
Dividend yield
2.04%
DPS
$2.88
Payout ratio
38.2%

DGX stock price

How has the Quest Diagnostics stock price performed over time
Intraday
0.89%
1 week
-2.12%
1 month
2.71%
1 year
7%
YTD
2.47%
QTD
6.14%

Financial performance

How have Quest Diagnostics's revenue and profit performed over time
Revenue
$9.29B
Gross profit
$3.05B
Operating income
$1.26B
Net income
$846M
Gross margin
32.9%
Net margin
9.1%
Quest Diagnostics's net margin has increased by 10% YoY
The net income has grown by 7% YoY
The company's operating margin rose by 6% YoY
The gross profit has decreased by 6% YoY

Growth

What is Quest Diagnostics's growth rate over time

Valuation

What is Quest Diagnostics stock price valuation
P/E
18.76
P/B
2.43
P/S
1.69
EV/EBIT
16.39
EV/EBITDA
12.08
EV/Sales
2.22
DGX's price to earnings (P/E) is 27% higher than its 5-year quarterly average of 14.8
DGX's EPS is up by 9% year-on-year
Quest Diagnostics's equity has increased by 6% YoY
The stock's price to book (P/B) is 2.8% less than its 5-year quarterly average of 2.5
The stock's price to sales (P/S) is 6% more than its last 4 quarters average of 1.6
The revenue has contracted by 3.3% YoY

Efficiency

How efficient is Quest Diagnostics business performance
DGX's return on sales is up by 13% year-on-year
Quest Diagnostics's return on invested capital has increased by 5% YoY
DGX's return on assets is down by 3.1% since the previous quarter
DGX's ROE is up by 3.1% year-on-year but it is down by 2.2% since the previous quarter

Dividends

What is DGX's dividend history
DPS
$2.88
Dividend yield
2.04%
Payout ratio
38.2%
Recent dividends

Financial health

How did Quest Diagnostics financials performed over time
The total assets is 86% greater than the total liabilities
The current ratio has decreased by 28% YoY and by 26% QoQ
Quest Diagnostics's quick ratio has decreased by 26% YoY and by 25% QoQ
Quest Diagnostics's debt is 17% lower than its equity
Quest Diagnostics's debt has increased by 16% YoY
The company's debt to equity rose by 9% YoY but it fell by 2.4% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.